Cited 0 times in
Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.